MUMBAI, India, May 30 -- Intellectual Property India has published a patent application (202517044157 A) filed by Keio University, Tokyo, on May 7, for 'diagnosis of immune-mediated inflammatory diseases using mmp12 as indicator, and medicine for treating immune-mediated inflammatory diseases via mmp12 inhibition.'
Inventor(s) include Matsumoto, Kotaro; Kaneko, Yuko; Suzuki, Katsuya; Hanaoka, Kenjiro; Sasaki, Eita; Takeshita, Masaru; Yamada, Sota; and Maruoka, Ryuta.
The application for the patent was published on May 30, under issue no. 22/2025.
According to the abstract released by the Intellectual Property India: "Provided are: a method for detecting immune-mediated inflammatory diseases characterized by an increase in the expression ...